Though “ESG” has entered the mainstream business lexicon only recently, GBC’s ethos has long centered on responsible innovation. Since 1984, the company has committed to developing affordable, high-impact diagnostic solutions that uplift health outcomes—without sacrificing environmental or ethical standards.
Reducing Environmental Impact
GBC continues to lead with sustainable manufacturing, from minimizing solvent use in chromatography and reaction workflows to transitioning toward reusable components. These measures aren’t just good for the planet—they enhance operational efficiency and reinforce investor confidence in a greener future.
Ethical Governance & Transparent Culture
At its core, GBC is driven by openness and integrity. These values guide interactions with employees, suppliers, and wider communities, reflecting a commitment to conduct business with transparency and responsibility—even in an era marked by industry scandals.
Health-First Mission, Responsibly Delivered
Creating leading-edge diagnostic tools comes with a responsibility to protect both people and the planet. GBC maintains a steadfast stance: innovation must align with ethical practice—evidenced through sustainable operations, manufacturing discipline, and a principled workplace.
Why GBC’s ESG Matters
• Sustainable Innovation: Delivering low-cost diagnostics at scale—without environmental compromise.
• Stakeholder Trust: Eco-conscious manufacturing builds reliability and credibility.
• Ethical Leadership: Strong governance fosters loyalty and confidence among staff, partners, and society.
GBC formed a Talent Sustainability Cooperation Alliance with Yuanpei University of Science and Technology to tightly couple teaching, research, and real-world application. The program equips students with clinical instrument proficiency, structured workshops, academic seminars, and industry internships, so graduates can step directly into precision-medicine roles and strengthen the national diagnostics workforce.
Academy–industry collaboration to scale testing
During the pandemic, GBC signed an MOU with Kaohsiung Medical University to co-develop rapid COVID-19 screening reagents and stand up automated, high-throughput workflows processing up to 1,440 samples/day. The goal: accelerate R&D and production as part of a broader “National Anti-Pandemic Team” with research institutes and hospitals—demonstrating mission-driven, cross-sector response when speed and accuracy matter most.
Knowledge exchange that lifts clinical quality
Interdisciplinary research groups aligned to infection control, clinical diagnosis, treatment, epidemiology, rapid testing, and vaccines enabled deep scientific exchange. GBC contributed expertise spanning immune proteins, DNA testing, product certification, clinical education, and product promotion, ensuring new methods could move from bench to bedside faster and more reliably.
Global vision, local action
Rooted in Hsinchu, GBC donated 20,000 rapid test kits to Hsinchu County/City and supported local hotels’ prevention programs, while engaging with city governments, health authorities, and hospitals to help set up community screening stations. The focus: strengthen local resilience, expand access to screening, and co-create a sustainable community alongside public partners.
Why it matters
• Future-ready talent: Early, hands-on training shortens the path from classroom to clinic.
As the pandemic surged, GBC rose to the challenge. Partnering with a major medical university, the company developed rapid COVID-19 test kits and implemented automated, high-throughput screening systems capable of processing up to 1,440 samples a day—ensuring swift identification and response during critical moments in epidemic control.
Sustained Diagnostic Performance
GBC’s diagnostic portfolio—including RT-PCR nucleic acid tests, antigen rapid kits, ELISA antibody tests, viral transport media, and extraction reagents—delivered over 90% accuracy across key variants, such as Alpha through Omicron. This reaffirmed GBC’s role in ensuring reliable diagnostics amid changing viral landscapes.
Strengthening Local Community Screening
At a time when national testing capacity was strained, GBC donated 20,000 RT-PCR test reagents to Hsinchu County and City. Simultaneously, the company engaged with municipal health authorities and hospitals to support the rapid establishment of community testing stations, strengthening grassroots epidemic surveillance and resilience.
Extending a Hand Globally
GBC also joined hands with a major foundation to donate 850 ELISA antibody test kits (enough to test over 81,600 individuals) to a friendly partner nation, demonstrating international solidarity. The Ministry of Foreign Affairs facilitated distribution, reinforcing how private, public, and philanthropic sectors can unite in global health crises.
Why it matters
• Innovation at scale: Demonstrated capability to respond to surging testing demands rapidly and accurately.
• Public health ally: Supported both local communities and international partners—highlighting GBC’s holistic approach to social responsibility.
• Resilience through partnership: Collaborative efforts across academia, government, NGOs, and health authorities underscore the impact of cross-sector action.
GBC recognized for ESG-driven workplace excellence
GBC has been awarded “Best Companies to Work for in Asia 2023” by HR Asia, a recognition of our commitment to a people-first ESG strategy that integrates sustainability, employee empowerment, and innovation. This honor reflects GBC’s belief that talent is the cornerstone of long-term success.
President Frank Lin: Talent at the heart of GBC’s growth
Mr. Frank Lin, President of GBC, emphasized that talent is the foundation of the company’s sustainable growth. Since its inception, GBC has been committed to fostering a workplace that prioritizes employee well-being, encourages cross-department collaboration, and invests in professional development.
GBC offers:
• Comprehensive benefits and allowances to support employees’ mental and physical health.
• Clear promotion systems and professional training programs to nurture long-term career growth.
• Rewarding policies for outstanding performance and diverse internal activities to build cohesion.
• A culture of openness that welcomes communication, feedback, and diverse perspectives across all teams.
Amidst the uncertainties of the COVID-19 pandemic, GBC stood firm on its commitment to job security—no layoffs, no salary reductions—safeguarding stability for every employee.
ESG as a core philosophy
GBC has embedded Environmental, Social, and Governance (ESG) principles into its DNA, striving to achieve balanced, sustainable growth:
• Environmental Responsibility: Implementing eco-conscious practices across R&D, production, and operations.
• Social Responsibility: Prioritizing employee welfare while making positive contributions to society through healthcare innovation.
• Transparent Governance: Maintaining high ethical standards, open communication, and accountability to stakeholders.
By empowering its people and aligning ESG values with its corporate mission, GBC is shaping a resilient organization capable of delivering breakthrough diagnostic solutions and improving global healthcare accessibility.
Looking ahead: Building a sustainable future
Frank Lin underscored GBC’s vision to become a global benchmark in diagnostic technology. This goal is driven by a belief that investing in people fuels innovation and industry leadership. GBC will continue to:
• Enhance employee engagement and professional development.
• Expand ESG-driven innovation to improve healthcare accessibility worldwide.
• Foster a workplace rooted in teamwork, fairness, harmony, and happiness.
• Make positive contributions to both the industry and society.
Call to action
At GBC, we believe sustainable innovation begins with people.
Discover how we integrate ESG values into everything we do — and join us to shape the future of healthcare.
Climate change and global warming pose unprecedented challenges for humanity. In line with Taiwan’s 2050 Net-Zero Emission Roadmap and international sustainability trends, GBC has launched a voluntary carbon inventory initiative to measure, analyze, and actively reduce its greenhouse gas emissions. This project is an integral part of GBC’s broader ESG strategy, reflecting its responsibility to protect both the environment and future generations.
Laying the Foundation With Data
Understanding emissions is the first step toward managing them. GBC is mapping every stage of its operations—from R&D labs and production facilities to logistics and distribution networks—to quantify Scope 1, Scope 2, and Scope 3 emissions.
• Scope 1: Direct emissions from GBC-owned facilities and equipment.
• Scope 2: Indirect emissions from purchased electricity and utilities.
• Scope 3: Upstream and downstream emissions across the supply chain.
By capturing this data, GBC can set science-based reduction targets and monitor progress against transparent benchmarks.
Driving Action: Reducing Carbon Footprint
Following the inventory, GBC will implement a multi-pronged action plan to reduce emissions while maintaining operational efficiency:
• Energy efficiency: Upgrading manufacturing equipment, optimizing HVAC systems, and investing in renewable energy sources where feasible.
• Sustainable production: Transitioning to low-solvent processes, adopting recyclable packaging, and reducing single-use materials.
• Green supply chain: Collaborating with upstream suppliers and downstream distributors to set shared sustainability goals and minimize lifecycle emissions.
This integrated approach ensures carbon reduction strategies are embedded across GBC’s entire ecosystem.
Employee Engagement: Sustainability Starts Within
GBC recognizes that true ESG success requires collective effort. As part of the carbon inventory program, the company is:
• Launching internal workshops to raise awareness of sustainability challenges.
• Encouraging employees to adopt energy-saving habits and eco-conscious behaviors at work and home.
• Empowering cross-departmental “green ambassadors” to drive change locally and foster a culture of environmental stewardship.
By aligning company-wide awareness with corporate goals, GBC ensures that sustainability is more than a policy—it becomes a shared identity.
Transparent Governance and Public Accountability
As part of its ESG framework, GBC commits to publishing results and updates from its carbon inventory. This ensures stakeholder trust and demonstrates GBC’s transparency in reporting progress towards its net-zero goals. Beyond regulatory compliance, this openness signals GBC’s dedication to long-term sustainable growth.
Aligning With Global Sustainability Trends
The launch of this project is not just about internal performance—it reflects GBC’s ambition to lead the diagnostics industry toward a greener, more responsible future. As diagnostic technologies evolve, so too must the environmental standards behind them. By embedding sustainability into product design, operations, and strategy, GBC is setting a new benchmark for responsible healthcare innovation.
In response to climate change and aligned with Taiwan’s 2050 Net-Zero Commitment, GBC has launched a voluntary carbon inventory program. This initiative represents a proactive step towards sustainable healthcare innovation by tracking, measuring, and managing greenhouse gas (GHG) emissions across operations.
By leveraging data-driven insights, GBC will identify opportunities to:
• Enhance energy efficiency across manufacturing facilities
• Implement low-carbon production processes
• Expand the use of renewable energy in R&D and operations
2. Building a Green and Transparent Supply Chain
Sustainability extends beyond GBC’s own facilities. Through green supply chain management, GBC collaborates with suppliers and partners to:
• Establish carbon reduction guidelines across the ecosystem
• Encourage low-emission material sourcing
• Support partners in adopting environmentally friendly practices
3. Empowering People to Drive ESG Forward
People are central to GBC’s ESG journey. Through employee training programs and sustainability awareness workshops, GBC empowers its workforce to:
• Understand climate impact and corporate responsibility
• Integrate green practices into daily operations
• Contribute ideas for continuous improvement
Conclusion
For GBC, ESG is more than a compliance exercise — it’s a long-term strategic priority.
The carbon inventory program is an important milestone that reflects GBC’s mission:
to innovate diagnostics and healthcare technologies while protecting the planet for future generations.
